Peter Macfarlane: h-index, Total Citations, and Citation Map
Peter Macfarlane's h-index is 96 (318 i10-index, 58,762+ total citations across 730+ publications) according to Google Scholar as of July 2026. Peter Macfarlane is affiliated with Emeritus Professor of Electrocardiology.
Peter Macfarlane is a researcher affiliated with Emeritus Professor of Electrocardiology, specializing in Automated ECG analysis. Their work has been cited 58,762 times. This profile visualizes their global influence, highlighting strong citation networks in United States.
Peter Macfarlane's Citation Metrics
Bibliometric impact based on 730 indexed publications.
- H-Index
- 96
- i10-Index
- 318
- Total Citations
- 58,762
- Citing Countries
- 68
As of July 2026.
Peter Macfarlane has an h-index of 96 and 58,762 total citations across 730 publications, with research cited by institutions in 68 countries.
Download Exports (PNG, CSV, Poster)
Free Viewing Peter Macfarlane's citation map is always free. Pay once to download poster, PNG, and CSV files for offline use or your visa packet.
We've mapped 5,000 of 58,762 citations for Peter Macfarlane
We've shown the most-cited 5,000. Unlock the full crawl (57,956 more citations) to see every institution citing this scholar.
Global Impact Map
Visualizing the geographic distribution of institutions that have cited your work.
Starting…
Pins will appear here as institutions are resolved — no need to refresh.
Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia
199510,065
Top Citing Countries
Top Citing Institutions
Visa Evidence Package
Views and exports tuned for EB-1A, O-1A, and EB-2 NIW petitions. Sustained acclaim, geographic reach, and independent-citation filtering are the strongest evidence categories immigration adjudicators look for.
Significant Contributions
Auto-detected research lines — a seminal paper and the follow-up work building on it. Review and edit before using in a petition. Each Free PDF opens in a new tab — EB-1A organises this into the structure USCIS applies to Criterion 5 of 8 CFR § 204.5(h)(3)(v); EB-1B re-frames it under § 204.5(i)(3) (outstanding researcher); NIW presents it under prong 2 of Matter of Dhanasar.
The researcher established the efficacy of pravastatin in preventing coronary heart disease among men with hypercholesterolemia, a seminal finding published in the New England Journal of Medicine.
The researcher conducted a landmark randomized controlled trial evaluating pravastatin efficacy in elderly patients at vascular risk, establishing critical evidence for statin therapy in this demographic.
The researcher established C-reactive protein as a critical predictor of coronary heart disease and diabetes within metabolic syndrome frameworks, significantly advancing cardiovascular risk stratification.
Citation trend (last 10 years)Click to expand
Citation Trend (Last 10 Years)
Related Guides
Learn how to use citation maps for your research and visa applications.
About Peter Macfarlane's research
Peter Macfarlane is a researcher in Automated ECG analysis at Emeritus Professor of Electrocardiology. Their work has been cited 58,762 times across 730 publications (h-index 96), according to Google Scholar.
Their most-cited work, “Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia” (1995), has accumulated 10,065 citations. Other influential works include “Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomised controlled trial” (2002) with 4,858 citations and “Statins and risk of incident diabetes: a collaborative meta-analysis of randomised statin trials” (2010) with 3,552 citations.
Citations of Peter Macfarlane's research come primarily from United States, United Kingdom and China, reflecting international research impact across 5+ countries. The interactive citation map above shows the full geographic distribution of the institutions citing this work.
